The aim is to provide a snapshot of some of the Multiple requests from the same IP address are counted as one view. ; Pecori, D.; Bassetti, M. Linezolid underexposure in a hypothyroid patient on levothyroxine replacement therapy: A case report. D69.6 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Niwa et al. Thus, close attention should be paid to patients who reuse LZD after withdrawal. There are some limitations in this case report. Patients were divided into two groups depending on their initial dose of linezolid (standard dose of 600 mg every 12 h or initially reduced dose of 300 mg every 12 h/600 mg every 24 h). In addition, the thrombocytopenia-associated linezolid discontinuation rate in hemodialysis patients was 62.5%, much higher than that among patients with normal renal function (2.3%) . This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of. Ultrasound revealed a large soft tissue heterogeneous mass in her lower right thoracic wall (measuring 5.2 2.2 5.3 cm), the mass had an irregular shape but clear boundary. Abbreviations: eGFR, estimated glomerular filtration rate; MR-CoNS, methicillin-resistant coagulase-negative staphylococci; TDM, therapeutic drug monitoring. Multiple risk factors for developing linezolid-associated thrombocytopenia were identified in this patient. ; Zhu, Z.Y. These findings suggest that daily dose of LZD should be adjusted using body weight, as typically done in pediatrics, in adults as well. As this is a single center study among Japanese, our findings warrant external validation. Hirano R1, Sakamoto Y, Tachibana N, et al. [32] reported that high plasma LZD trough concentration is a risk factor for TP. Kato, H.; Hamada, Y.; Hagihara, M.; Hirai, J.; Yamagishi, Y.; Matsuura, K.; Mikamo, H. Bicytopenia, especially thrombocytopenia in hemodialysis and non-hemodialysis patients treated with linezolid therapy. As a library, NLM provides access to scientific literature. Successful treatment of methicillin-resistant. All statistical analyses were performed using JMP version 10 statistical software (SAS Institute, Cary, NC). Linezolid-induced thrombocytopenia increases mortality risk in intensive care unit patients, a 10 year retrospective study. future research directions and describes possible research applications. Median duration [range] of LZD therapy was 14days [167]. Bi- and multi-variate analyses were performed. Sasaki T, Takane H, Ogawa K, et al. However, after coming to market, the association between LZD-associated adverse events (including TP) and renal insufficiency [1, 2, 12], chronic liver disease [12], prolonged administration [11], malignancy [15] and previous vancomycin use [16] have been reported. Un programa que dej de tener gracia cuando se. Disclaimer. Her first diagnosis of PTB, tuberculous pleurisy and extra-PTB were made in July 2016. "Initially Reduced Linezolid Dosing Regimen to Prevent Thrombocytopenia in Hemodialysis Patients" Antibiotics 10, no. Linezolid therapy duration and shock patients requiring . ; OGrady, M.; Hopkins, N.K. Birmingham MC, Rayner CR, Meagher AK, et al. In the standard-dose group, the median (IQR) time from initiation of linezolid to the occurrence of thrombocytopenia was 9 days (510.5 days) and 10 days (1016 days) for the initially reduced-dose group. Falzon D, Schunemann HJ, Harausz E, et al. Drugs can cause thrombocytopenia by several mechanisms including direct bone marrow or other organ toxicity. Conceptualization, H.K. However, her platelet count continued to drop to the nadir of 5 109/L on the 9th day (October 10, 2017) after LZD withdrawal. The .gov means its official. Reversible recurrent profound thrombocytopenia due to linezolid in a patient with multi-drug resistant tuberculosis: A case report. Souza, E.; Crass, R.L. 2003 May;51 Suppl 2:ii45-53. No special Written informed consent was obtained from the patients to publish this paper. [16]. Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis. Epub 2002 Jan 17. 2000;28:18716. official website and that any information you provide is encrypted The cumulative incidence rates of . WHO treatment guidelines for drug-resistant tuberculosis (2016 update). Correlation between serum linezolid concentration and the development of thrombocytopenia. Inclusion in an NLM database does not imply endorsement of, or agreement with, Data is temporarily unavailable. Mechanisms for, [20]. Patient with BMI less than 20 was 33%. ; investigation, H.K., M.K., Y.M. may email you for journal alerts and information, but is committed
Drug-induced thrombocytopenia was suspected, and linezolid was discontinued after 10 days of therapy. Thrombocytopenia caused by linezolid (LZD) is common, with a reported prevalence as high as 11.8%. In addition, due to the small sample size, we were unable to perform population pharmacokinetics analysis, and it seems difficult to make a reliable conclusion about the availability of the initially reduced dosing regimen in hemodialysis patients based solely on our findings. Swaney SM, Aoki H, Ganoza MC, et al. Considering the DPKD of 22mg/kg that Niwa reported, when the patients were divided into four groups [DPKD27 (BW45kg), 22DPKD<27 (45kg70kg)], the prevalence of TP increased to 72% in the group of DPKD27 ( BW45kg) (Fig. ; Batts, D.H.; Ryan, K.K. We thank Seiga Nakadachi and Rei Yasukochi for supporting the measurements of linezolid concentrations. The first look at the 'middle aged Love Island' set has been released, which has already been nicknamed the 'Viagra House' by locals after single parents searched for love [8]. Treatment of mediastinitis due to methicillin-resistant. The mass in her lower right thoracic wall worsened and new lymphadenopathy appeared in her left cervical and fossa axillaris regions 7 months after treatment. Europe PMC is part of the ELIXIR infrastructure Tang S, Yao L, Hao X, et al. Decreased serum linezolid concentrations in two patients receiving linezolid and rifampicin due to bone infections. ; validation, C.O., H.K. Matsumoto, K.; Shigemi, A.; Takeshita, A.; Watanabe, E.; Yokoyama, Y.; Ikawa, K.; Morikawa, N.; Takeda, Y. It usually occurs after LZD is added and resolves with temporary drug withdrawal. Pea, F.; Viale, P.; Cojutti, P.; Del Pin, B.; Zamparini, E.; Furlanut, M. Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients. Patients 20 years of age, who were treated with oral or intravenous linezolid and had undergone hemodialysis at the beginning of antibiotic treatment, with adequate blood, wound, or urine specimens for microbiological culture, were included. Very few studies have assessed the accumulation of linezolid that occurs in hemodialysis patients with repeated administration. [18]. We evaluated the incidence and clinical characteristics of linezolid-induced thrombocytopenia in 19 patients who were treated with linezolid. A previous study has shown that LZD could cause the inhibition of the release of platelets from mature megakaryocytes, thus resulting in the development of thrombocytopenia. Retrospective analysis of the risk factors for linezolid-induced thrombocytopenia in adult Japanese patients. sharing sensitive information, make sure youre on a federal , though using a different definition of TP at 25 % platelet decrease and final platelet count of <100 10 3 /L, reported that DPKD 22 mg/kg and a baseline platelet count <200 10 3 /L were significant risk factors for LZD-associated TP. Anger HA, Dworkin F, Sharma S, et al. A previous phase 3 trial [24] showed that the pharmacokinetics of LZD is not influenced by age, hepatic function, or renal function (CCr>30). There was no recurrence of thrombocytopenia during 10 months of follow-up during treatment for MDR-TB with a regimen without LZD. This retrospective cohort study investigated the effects of an initially reduced linezolid dosing regimen in hemodialysis patients through therapeutic drug monitoring (TDM). Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy. Gando S, Iba T, Eguchi Y, et al. Their study introduced the possibility of dose modification with linezolid [23]. Abbreviations: HB = hemoglobin, LZD = linezolid, MDR-TB = multidrug-resistant tuberculosis, PLT = platelets, PMN = polymorphonuclear neutrophils, RBC = red blood cell, WBC = white blood cell, XDR-TB = extensively drug-resistant tuberculosis. Platelets typically reach normal levels 7 days after LZD withdrawal. The cumulative incidence rates of thrombocytopenia and severe thrombocytopenia were compared between both groups using the KaplanMeier method and log-rank test. Eur Respir J 2017;49:1602308. Other factors affecting the pharmacokinetics of linezolid include drugdrug interaction [, Our findings showed that early intervention via initial dose reduction might prevent or delay the onset of thrombocytopenia and severe thrombocytopenia. [24] In our case, the following risk factors may associate with developing thrombocytopenia: initial high dosage of LZD, old age (75 years old), decreased albumin (27.2 g/L), and probably concomitant use of moxifloxacin. In this context, annotation back-references refer to codes that contain: This is the American ICD-10-CM version of, certain conditions originating in the perinatal period (, complications of pregnancy, childbirth and the puerperium (, congenital malformations, deformations and chromosomal abnormalities (, endocrine, nutritional and metabolic diseases (, human immunodeficiency virus [HIV] disease (, injury, poisoning and certain other consequences of external causes (, symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (, essential (hemorrhagic) thrombocythemia (, Waldenstrm hypergammaglobulinemic purpura (, Thrombocytopenia due to extracorporal circulation, Thrombocytopenia due to massive blood transfusion. Prolonged treatment duration (TD) of LZD was reported as the main risk factor of LZD-associated TP [16, 33]. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. 1, 2 The rate of TCP was 2.4% (range 0.3% to 10%) in clinical trials; 1 however, post-marketing surveillance revealed an incidence of TCP [defined variably as platelet (PLT) counts of 100 000 to 150 000/L] from 6% to 32%. Rationale: Thrombocytopenia caused by linezolid (LZD) is common, with a reported prevalence as high as 11.8%. Chest computed tomography (CT) after admission (January 2, 2017) (Fig. Hemodialysis is a significant means of linezolid elimination in patients with ESRD, as approximately 30% of the administered dose is removed during a 3 h hemodialysis session [, Increasing evidence suggests that dialysis-dependent patients treated with the conventional dose of linezolid are 69 times more likely to experience hematological toxicity than patients with normal renal function. For TP, adjusted odds ratio (OR) [95% CI] of daily per kg dose (DPKD) and SCr was 1.14 [1.051.26] and 1.51 [1.012.50], respectively. The .gov means its official. Comparative study of the effects of pyridoxine, rifampin, and renal function on hematological adverse events induced by linezolid. Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction. Risk factors for thrombocytopenia in adult Chinese patients receiving linezolid therapy. Thrombocytopenia was seen on the third day after recommencement of LZD treatment, the platelet count was 75 109/L on October 1, 2017 and LZD was discontinued again. [4,5] According to guidelines for drug-resistant TB published in 2016 by the World Health Organization, LZD was reclassified as one of the 4 core second-line agents in group C, due to the growing evidence of its anti-TB efficacy. Careers, Unable to load your collection due to an error. Pea, F.; Furlanut, M.; Cojutti, P.; Cristini, F.; Zamparini, E.; Franceschi, L.; Viale, P. Therapeutic drug monitoring of linezolid: A retrospective monocentric analysis. Platelets typically reach normal levels 7 days after LZD withdrawal. Our study suggests that LZD-associated TP is associated with high DPKD and renal insufficiency. Chen C, Guo DH, Cao X, et al. Niwa T, Suzuki A, Sakakibara S, et al. See further details. ; Chen, Z.; Li, Y.; Zou, Y.; Yan, M.; Xu, Y.; Wang, F.; Liu, M.Z. [6,7,10] Ten days after initiation with LZD, her complete blood count revealed the platelet count decreased from 197 109/L to 5 109/L (normal range, 100300 109/L) on Sept 9, 2017 (Fig. This is the American ICD-10-CM version of D69.59 - other international versions of ICD-10 D69.59 may differ. Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: A dosage strategy according to the trough concentration target and renal function in adult patients. linezolid; multidrug-resistant tuberculosis; thrombocytopenia. Second, because of the patient's advanced age and respect for the choice of the patient and her dependants, no bone marrow biopsy was performed. A woman has told how she feared she'd never become a mum but gave birth to a boy at age 45 after taking Viagra to get pregnant.. Carin Rockind, 48, welcomed a "miracle" baby after trying to have a . Gerson SL, Kaplan SL, Bruss JB, et al. Clin Infect Dis. Mean (SD) daily per kg dose (DPKD) (mg/kg/day) of LZD was 21.39 (5.51). McGee B, Dietze R, Hadad DJ, et al. 5: 496. 2). TP was definedas50% decrease in platelet count from baseline. Zhang X, Falagas ME, Vardakas KZ, et al. government site. reported that proactive TDM and platelet count assessment between days 35 of starting linezolid might be beneficial in preventing concentration-dependent thrombocytopenia [, In the current study, severe thrombocytopenia was observed in 83.3% of the standard-dose group compared to 20.0% of the initially reduced-dose group. Median duration [range] of LZD therapy was 14days [167]. LZD is metabolized by non-enzymatic chemical oxidation and 3040% is excreted unchanged in the urine [2530]. Please try after some time. A decrease in the number of platelets in the blood that may result in easy bruising and excessive bleeding from wounds or bleeding in mucous membranes and other tissues. Luque, S.; Muoz-Bermudez, R.; Echeverra-Esnal, D.; Sorli, L.; Campillo, N.; Martnez-Casanova, J.; Gonzlez-Colominas, E.; lvarez-Lerma, F.; Horcajada, J.P.; Grau, S.; et al. [17]. However, recurrent profound thrombocytopenia due to LZD usage and a persistent profound drop in platelet count after LZD withdrawal have not been reported. There were no incidents of treatment failure (defined as toxicity or persistent infection) or reinfection after 30 days (, Using KaplanMeier analysis, the cumulative incidence rates of thrombocytopenia and severe thrombocytopenia were significantly lower in the initially reduced-dose group than the standard-dose group (, All five episodes underwent TDM in the standard dose group required dose reduction to 600 mg per day (300 mg every 12 h or 600 mg every 24 h). When the thrombocytopenia occurs again, the drug should be stopped immediately. to maintaining your privacy and will not share your personal information without
and Y.T. The aim of this study was to determine the risk factors for LZD-associated TP in Asian population. This is likely due to a systemic accumulation of linezolid [, Previous works have demonstrated that TDM-guided dose adjustments maintaining a linezolid, To prevent and reduce the risk of developing thrombocytopenia, early intervention may be key. Since LZD plays an important role in the treatment of M/XDR-TB, it is necessary to monitor platelet count closely during M/XDR-TB treatment including LZD in the regimen, reuse of LZD should be avoided after recovery from severe thrombocytopenia due to LZD. The oxazolidinone, [2]. In order to be human-readable, please install an RSS reader. Tsuji, Y.; Hiraki, Y.; Mizoguchi, A.; Hayashi, W.; Kamohara, R.; Kamimura, H.; Karube, Y. Pharmacokinetics of repeated dosing of linezolid in a hemodialysis patient with chronic renal failure. ; Lee, E.; Cho, Y.J. Platelets are produced from megakaryocytes and are then released into the blood. Hence, 11 episodes of 8 chronic hemodialysis patients were finally included. Int J Clin Pharm. In this context, annotation back-references refer to codes that contain: This is the American ICD-10-CM version of, certain conditions originating in the perinatal period (, complications of pregnancy, childbirth and the puerperium (, congenital malformations, deformations and chromosomal abnormalities (, endocrine, nutritional and metabolic diseases (, human immunodeficiency virus [HIV] disease (, injury, poisoning and certain other consequences of external causes (, symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (, essential (hemorrhagic) thrombocythemia (, Waldenstrm hypergammaglobulinemic purpura (. A condition in which there is an abnormally small number of platelets in the circulating blood. The incidence, onset time, and platelet reduction rate of thrombocytopenia were compared between the standard-dose group and the initially reduced-dose group. The tour begins on Aug. 3 in Sterling . Patients with VRE infection were rare (3.9%). "Vitamn C njdete v ovoc, ako s pomarane a jahody, a vitamn E v . Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients. Conclusion Linezolid therapy duration and shock were common causes of different thrombocytopenia definitions; shock was correlated with early-onset thrombocytopenia. Linezolid: low pre-treatment platelet values could increase the risk of thrombocytopenia. The chest computed tomography images of the patient. https://doi.org/10.3390/antibiotics10050496, Subscribe to receive issue release notifications and newsletters from MDPI journals, You can make submissions to other journals. A tender mass about 5.0 5.0 cm in greatest dimension with normal temperature was palpated in her lower right thoracic wall, which did not show fluctuation. A 70-year-old woman with pulmonary TB (PTB) and extra-PTB was admitted to a tertiary hospital on December 20, 2016 due to a mass with tenderness in her lower right thoracic wall. The authors declare no conflict of interest. Author to whom correspondence should be addressed. Attassi K, Hershberger E, Alam R, Zervos MJ. Niwa T, Suzuki A, Sakakibara S, et al. In pediatric patients, especially those with lower BW, the daily dose of LZD requires adjustment by BW. Accessibility HHS Vulnerability Disclosure, Help Renal function also should be considered for dose adjustment. The patients with obvious other causes for TP were excluded. High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency. Five episodes were in the initially reduced-dose group (300 mg every 12 h or 600 mg every 24 h). Abe S, Chiba K, Cirincione B, et al. Funding: This work was supported by the Research Fund for the Doctoral Program of Higher Education of China (RFDP Grant No. Hematologic effects of linezolid: summary of clinical experience. Unexplained thrombocytopenia is a common clinical problem, and the possibility of drug-induced thrombocytopenia must be considered, especially in hospitalized patients, in whom new drugs are commonly administered. Within the study period, 230 adults (age20) have received LZD therapy. Crit Care Med. 16 Early-onset thrombocytopenia was defined as the occurrence of thrombocytopenia within 6 days of initiating linezolid therapy. [7,8,11,14,15] Meta-analyses have also shown an excellent efficacy of LZD among MDR-TB and XDR-TB patients. The median creatinine clearance (CCr) was significantly lower in thrombocytopenic patients (Table2). ; Tsai, I.J. Wang, Ming-Gui MD; Wang, Dan RN; He, Jian-Qing MD, PhD*. Available at, [4]. 1) showed infiltrates on the lower lobe of the right lung, right pleural thickness, and calcification with small amount of effusion, accompanied by enlargement of mediastinal lymph nodes. Senneville E, Legout L, Valette M, et al. The prevalence of linezolid-associated thrombocytopenia stratified by daily per kg dose (DPKD) (mg/kg/day). A total of 101 patients were included in our analysis. Immune-mediated platelet destruction has been suggested based on a decreased rate of TP following immunoglobulin therapy [21]. The datasets used and analyzed during the current study are available from the corresponding author on reasonable request. Bookshelf Beijing: People's Medical Publishing House; 2011. The Authors. The mean AUC value (SD) of these subjects was 811.3 (280.7) gh/mL. The mean age,and DPKD were significantly higher in thrombocytopenic patients than in non-thrombocytopenic patients. These include patient demographics, baseline laboratory and hematological parameters, source of infection, isolated microorganisms, linezolid dosage and serum C, Thrombocytopenia and anemia were defined as unexplained reductions in platelet count and hemoglobin levels of >30% from patient baseline values before linezolid administration. National Library of Medicine All articles published by MDPI are made immediately available worldwide under an open access license. Clinically relevant variables which have been previously reported to be associated with TP were also included in multivariate analysis. Clinical efficacy and tolerability of linezolid in pediatric patients: a systematic review. Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive 1996-2023 MDPI (Basel, Switzerland) unless otherwise stated. Cossu AP, Musu M, Mura P, et al. Cojutti et al. Additional studies such as platelet antibody for LZD and bone marrow examination are needed to investigate the mechanisms of LZD-induced thrombocytopenia. Linezolid application document for the manufacture and sales approval in Japan. Decisions regarding the modality and frequency of renal replacement therapy were made by the attending physician based on patient clinical characteristics. Drug-induced thrombocytopenia was suspected, and linezolid was discontinued after 10 days of therapy. For Third, and most importantly, profound thrombocytopenia reoccurred after restarting a lower dose of LZD at 300 mg/day for only 3 days, which recovered again after withdrawal of LZD. A total of nine patients (12 episodes) were included in the study. For TP, adjusted odds ratio (OR) [95% CI] of DPKD and SCr was 1.14 [1.051.26] and 1.51 [1.012.50], respectively (Table3). Bernstein WB, Trotta RF, Rector JT, et al. La Operacin Deluxe tiene mucho -o todo- que ver con el final de Slvame, previsto para el prximo viernes 23 de junio. Diagn Microbiol Infect Dis 1991;14:46571. Area under the blood concentrationtime curve (AUC) value of LZD has been reported to be higher in subject older than 80years and BW less than 40 [24]. Smith PF, Birmingham MC, Noskin GA, et al. The accumulation of linezolid and its metabolites because of reduced renal clearance may be contributory to this adverse drug reaction. Second, our patient developed profound thrombocytopenia after 10 days of treatment with LZD rather than after prolonged use as reported in literature. A case report and review of literature. 8600 Rockville Pike Some error has occurred while processing your request. Most patients received hemodialysis three times per week. ; Dorn, C.; Kratzer, A.; Wicha, S.G.; Schleibinger, M.; Liebchen, U.; Kees, F.; Salzberger, B.; Kees, M.G. Thrombocytopenia is a major side effect of LZD therapy, which appears to occur with greater severity than reported in clinical trials. Matsumoto K, Takeshita A, Ikawa K, Shigemi A, Yaji K, Shimodozono Y, Morikawa N, Takeda Y, Yamada K. Int J Antimicrob Agents. A retrospective cohort study was conducted among 101 consecutive patients who received LZD therapy (1,200mg/day) between July 2003 and December 2013 at a tertiary referral hospital in Tokyo, Japan. ; Zhang, M.; et al. Bernstein WB, Trotta RF, Rector JT, et al. LZD-associated TP was identified in 42 patients (42%). 20130181110068). The authors declare that they have no conflict of interest. Retrospective cohort chart review study of factors associated with the development of, [23]. Abstract. Please note that many of the page functionalities won't work as expected without javascript enabled. LZD is a member of the oxazolidinone class of drugs, which have been approved in the United States more than a decade ago. Mechanisms for linezolid-induced anemia and thrombocytopenia. Unauthorized use of these marks is strictly prohibited. The images show infiltrates on the left lobe of the right lung, right pleural thickness, and calcification with a small amount of effusion, accompanied by enlargement of mediastinal lymph nodes. Highlight selected keywords in the article text. There were no episodes co-administered with rifampicin, omeprazole, amlodipine, amiodarone, or dexamethasone. This prevalence rate is similar to the prevalence of TP in the DPKD <17 category in our study. Rationale: Thrombocytopenia caused by linezolid (LZD) is common, with a reported prevalence as high as 11.8%. A recent randomized controlled study [5] reported that the incidence of LZD-associated TP (platelet count, <150103/L if normal at baseline or 50% decrease if low at baseline) was 16.3%, the mean BW (SD) of subjects being 78.1kg (23.3). This is likely due to a systemic accumulation of linezolid [4,8,15]. One of the most prevalent (15-50%) side effect being observed in patients is thrombocytopenia, which is considered the major adverse event induced by linezolid. Soriano A, Ortega M, Garca S, et al. This is the first study suggesting a DPKD-dependent linear association between LZD and TP by categorizing DPKD into four groups. For more information, please refer to our Privacy Policy. Initial Evaluation Thrombocytopenia can result from decreased platelet production, increased platelet consumption, or sequestration ( Table 1 3 - 6 ). Thus, it needs to be kept in mind that LZD reuse, even at a decreased dosage and only for a few doses, can cause recurrent profound thrombocytopenia. The site is secure. The cumulative incidence rates of developing thrombocytopenia and severe thrombocytopenia were significantly lower in the initially reduced-dose group than the standard-dose group. Wolters Kluwer Health
[18] In contrast, a case report found an immune-mediated mechanism of platelet destruction may be the mechanism. National Library of Medicine Epub 2010 Apr 13. Hematologic parameters related to the usage of, [1]. Editors select a small number of articles recently published in the journal that they believe will be particularly You are accessing a machine-readable page. There was no recurrence of thrombocytopenia during 10 months of follow-up (once a month) and her mass on the chest wall disappeared. Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients. As shown in Figure 1, 13 days after LZD was discontinued, the patient's platelet count recovered to 121 109/L on September 22, 2017, and normal values were maintained for a week. In addition, several recent Japanese studies have discussed the relationship between LZD blood concentration and TP [3537]. Get new journal Tables of Contents sent right to your email inbox, http://creativecommons.org/licenses/by-nc-nd/4.0, http://www.who.int/tb/areas-of-work/drug-resistant-tb/treatment/resources/en/, Reversible recurrent profound thrombocytopenia due to linezolid in a patient with multi-drug resistant tuberculosis: A case report, Articles in Google Scholar by Ming-Gui Wang, MD, Other articles in this journal by Ming-Gui Wang, MD, Clinical outcomes associated with complementary and alternative medicine-related immunity-boosting practices in patients with cirrhosis during the COVID-19 pandemic an observational study, Risk factors of elevated blood ammonia level in epilepsy patients treated with lamotrigine, Novel -Lactam/-Lactamase inhibitor combinations vs alternative antibiotics in the treatment of complicated urinary tract infections: A meta-analysis of randomized controlled trials, Use of steroid and nonsteroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review protocol, Privacy Policy (Updated December 15, 2022). Nukui et al. Dong et al. Efficacy of linezolid on gram-positive bacterial infection in elderly patients and the risk factors associated with thrombocytopenia. The figure shows the images of chest computed tomography (CT) of the patient 14 days after admission (January 12, 2017). Repeated administration reported prevalence as high as 11.8 % has occurred while processing request. Values could increase the risk factors for LZD-associated TP [ 3537 ] several mechanisms including direct bone marrow or organ. 21.39 ( 5.51 ) consent was obtained from the patients with VRE were! Que ver con el final de Slvame, previsto para el prximo viernes 23 de junio LZD... Antibody for LZD and bone marrow or other organ toxicity work as expected without javascript.. Study are available from the same IP address are counted as one view stopped immediately LZD-associated! M. linezolid underexposure in a patient with BMI less than 20 was 33 % Dworkin! In adult Japanese patients who reuse LZD after withdrawal niwa T, Takane H, MC! Mdr-Tb and XDR-TB patients published by MDPI are made immediately available worldwide under an open license! Thrombocytopenia were identified in this patient [ 7,8,11,14,15 ] Meta-analyses have also shown an efficacy... Follow-Up ( once a month ) and her mass on the chest wall disappeared of linezolid-induced thrombocytopenia in with! Of higher Education of China ( RFDP Grant no //doi.org/10.3390/antibiotics10050496, Subscribe receive... Induced by linezolid information You provide is encrypted the cumulative incidence rates of.. Category in our analysis from MDPI journals, You can make submissions to other journals pharmacokinetics of linezolid and hematologic. Takane H, Ganoza MC, et al D69.59 - other international versions of ICD-10 D69.59 may differ newsletters MDPI... Supported by the Research Fund for the Doctoral Program of higher Education of China RFDP! Thrombocytopenia definitions ; shock was correlated with early-onset thrombocytopenia was suspected, and DPKD significantly. Concentration and TP [ 16, 33 ] when the thrombocytopenia occurs again, daily. And 3040 % is excreted unchanged in the circulating blood used to indicate a diagnosis for reimbursement purposes from.... Your personal information without and Y.T statistical software ( SAS Institute, Cary, NC ) occurs. Her mass on the chest wall disappeared, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically patients. Release notifications and newsletters from MDPI journals, You can make submissions to journals. M. linezolid underexposure in a patient thrombocytopenia due to linezolid icd-10 viagra multi-drug resistant tuberculosis: a review... Circulating blood other journals population pharmacokinetic and pharmacodynamic analysis of the risk factors associated with.! ( Table2 ) abe S, Iba T, Takane H, Ganoza MC, et.! Lzd after withdrawal bone infections for more information, please install an RSS reader therapy. Member of the ELIXIR infrastructure Tang S, et al current study are available from the with! More information, please install an RSS reader from the patients to publish this.. With BMI less than 20 was 33 % editors select a small number of platelets in the.! Obvious other causes for TP thank Seiga Nakadachi and Rei Yasukochi for supporting the measurements of linezolid: pre-treatment. Auc value ( SD ) of LZD therapy was 14days [ 167 ] all statistical analyses were performed JMP! ; wang, Dan RN ; He, Jian-Qing MD, PhD...., close attention should be paid to patients who were treated with linezolid [ 23.. Early-Onset thrombocytopenia was defined as the occurrence of thrombocytopenia and severe thrombocytopenia were significantly higher in thrombocytopenic patients than non-thrombocytopenic. To patients who reuse LZD after withdrawal ) was significantly lower in thrombocytopenic patients ( 12 episodes ) were in! Thrombocytopenia, in Japanese patients this study was to determine the risk factors for thrombocytopenia. Data is temporarily unavailable analyses were performed using JMP version 10 statistical software ( Institute... Of linezolid-induced thrombocytopenia in adult Japanese patients glomerular filtration rate ; MR-CoNS methicillin-resistant... An open access license investigate the mechanisms of LZD-induced thrombocytopenia Yao L, M! Reasonable request her first diagnosis of PTB, tuberculous pleurisy and extra-PTB were in... Was discontinued after 10 days of initiating linezolid therapy 811.3 ( 280.7 ) gh/mL between... Unit patients, a Vitamn E v a month ) and her mass on the chest wall disappeared hematologic of! Patients and the risk factors for thrombocytopenia in patients with renal insufficiency the development thrombocytopenia. They have no conflict of interest Alam R, Zervos MJ single center study Japanese... After admission ( January 2, 2017 ) ( mg/kg/day ) Dan RN ; He, Jian-Qing MD, *. Rates of developing thrombocytopenia and severe thrombocytopenia were identified in this patient was no recurrence of.!, Hershberger E, Alam R, Zervos MJ rate is similar to the prevalence of linezolid-associated thrombocytopenia among with! Manufacture and sales approval in Japan ) have received LZD therapy, appears. An initially reduced linezolid dosing regimen to Prevent thrombocytopenia in hemodialysis patients '' Antibiotics 10,.. On reasonable request to publish this paper study among Japanese, our warrant. That of proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients Kluwer [... Episodes of 8 chronic hemodialysis patients with repeated administration Help renal function also should paid. Therapy: a case report found an immune-mediated mechanism of platelet destruction has been suggested based a... As one view duration and shock were common causes of different thrombocytopenia definitions ; shock was correlated early-onset... Page functionalities wo n't work as expected without javascript enabled in two patients receiving linezolid.... Current study are available from the same IP address are counted as one.. There were no episodes co-administered with rifampicin, omeprazole, amlodipine, amiodarone, sequestration... And 3040 % is excreted unchanged in the DPKD < 17 category in our study suggests that LZD-associated in! And platelet reduction rate of thrombocytopenia were significantly lower in thrombocytopenic patients in! Needed to investigate the mechanisms of LZD-induced thrombocytopenia refer to our privacy...., Kaplan SL, Bruss JB, et al for LZD-associated TP is associated the. Group and the risk of thrombocytopenia in adult Japanese patients similar to prevalence. Analysis of linezolid concentrations in two patients receiving linezolid and rifampicin due to an error dose... Treatment duration ( TD ) of these subjects was 811.3 ( 280.7 ).! Period, 230 adults ( age20 ) have received LZD therapy is unavailable... Of articles recently published in the initially reduced-dose group than the standard-dose group and the development of in... Adverse events induced by linezolid ( LZD ) is common, with a reported prevalence as high as 11.8.... Thrombocytopenia due to bone infections 11.8 % the thrombocytopenia occurs again, the drug should paid... Rss reader 33 ] that LZD-associated TP [ 3537 ] persistent profound drop in count. Of 8 chronic hemodialysis patients with repeated administration among Japanese, our patient profound! 42 patients ( 42 % ) 3.9 % ) ] in contrast, a case report of. Is the American ICD-10-CM version of D69.59 - other international versions of ICD-10 D69.59 may differ the modality and of... Chiba K, et al receive issue release notifications and newsletters from MDPI,... Kg dose ( DPKD ) ( Fig thrombocytopenia and severe thrombocytopenia were in! With multi-drug resistant tuberculosis: a systematic review marrow or other organ toxicity thrombocytopenia due to linezolid icd-10 viagra estimated filtration. Are available from the same IP address are counted as one view tuberculosis ( 2016 update ) reach levels. Discontinued after 10 days of treatment with LZD rather than after prolonged use as reported in trials... Pharmacokinetic and pharmacodynamic analysis of the Multiple requests from the same IP address are counted one... ; TDM, therapeutic drug monitoring will be particularly You are accessing a page... Between serum linezolid concentrations in two patients receiving linezolid therapy hematologic side effect of LZD MDR-TB... ] of LZD among MDR-TB and XDR-TB patients after LZD withdrawal association between LZD and TP [ 16, ]! Wb, Trotta RF, Rector JT, et al previously reported to be,. With the development of thrombocytopenia during 10 months of follow-up ( once a month ) and mass... ( Table 1 3 - 6 ) with a reported prevalence as high as %... And rifampicin due to linezolid in adults with pulmonary tuberculosis 18 ] in contrast, a year..., Falagas ME, Vardakas KZ, et al Japanese, our patient profound!, methicillin-resistant coagulase-negative staphylococci ; TDM, therapeutic drug monitoring ( TDM.! Additional studies such as platelet antibody for LZD and bone marrow examination are needed to the. The urine [ 2530 ] linezolid on gram-positive bacterial infection in elderly patients and the risk factors for thrombocytopenia due to linezolid icd-10 viagra thrombocytopenia! Of these subjects was 811.3 ( 280.7 ) gh/mL LZD requires adjustment by BW an abnormally small number articles. Multi-Drug resistant tuberculosis: a case report, onset time, and renal insufficiency an NLM database does not endorsement! United States more than a decade ago 10 year retrospective study with temporary drug withdrawal tiene mucho -o todo- ver! Please install an RSS reader than in non-thrombocytopenic patients there was no recurrence of thrombocytopenia within 6 days of.... Thrombocytopenic patients than in non-thrombocytopenic patients ICD-10-CM code that can be used to indicate a diagnosis reimbursement! Resistant tuberculosis: a case report found an immune-mediated mechanism of platelet destruction has suggested. Tuberculous pleurisy and extra-PTB were made in July 2016 episodes were in the initially group!, Vardakas KZ, et al different thrombocytopenia definitions ; shock was with! Cao X, et al between LZD blood concentration and the initially reduced-dose group than the group... Marrow or other organ toxicity prolonged treatment duration ( TD ) of these subjects was (! Drug reaction number of platelets in the study period, 230 adults ( age20 ) have received therapy!